Ondine Biomedical (FRA:VF5) ROE % Adjusted to Book Value: -93.26% (As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical ROE % Adjusted to Book Value?

Ondine Biomedical FRA:VF5 -23.08% 47 ROE % Adjusted to Book Value is -93.26% as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

Ondine Biomedical's ROE % for the quarter that ended in Dec. 2024 was -657.50%. Ondine Biomedical's PB Ratio for the quarter that ended in Dec. 2024 was 7.05. Ondine Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -93.26%.

Ondine Biomedical ROE % Adjusted to Book Value Related Terms

Ondine Biomedical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical ROE % Adjusted to Book Value Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -19.02 -16.34 -60.18

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.05 -24.79 -32.64 0.00 -93.26

FRA:VF5 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Ondine Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's ROE % Adjusted to Book Value falls into.


FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical ROE % Adjusted to Book Value Calculation

Ondine Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-424.26% / 7.05
=-60.18%

Ondine Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-657.50% / 7.05
=-93.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -93.26% mean?
Ondine Biomedical (FRA:VF5) has a ROE % Adjusted to Book Value of -93.26% as of Dec. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's ROE % Adjusted to Book Value too high?
Ondine Biomedical's current ROE % Adjusted to Book Value is -93.26%. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's ROE % Adjusted to Book Value compare to VRTX and REGN?
Ondine Biomedical's ROE % Adjusted to Book Value of -93.26% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current ROE % Adjusted to Book Value is -93.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current ROE % Adjusted to Book Value of -93.26%. The current ROE % Adjusted to Book Value is -93.26%. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current ROE % Adjusted to Book Value is -93.26% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price